Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome

Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome (SEMD-hypotrichosis) is an extremely rare genetic skeletal disorder characterized by the combination of a specific pattern of bone abnormalities (spondyloepimetaphyseal dysplasia) and sparse hair (hypotrichosis). The condition affects the skeletal system broadly, with abnormalities involving the vertebrae (spondylo-), the ends of long bones (epiphyseal), and the regions adjacent to the growth plates (metaphyseal). Affected individuals typically present with short stature, which becomes apparent in early childhood, along with skeletal features such as platyspondyly (flattened vertebral bodies), short limbs, and irregularities of the epiphyses and metaphyses visible on X-ray. The ectodermal involvement manifests as hypotrichosis, meaning patients have notably sparse or thin scalp hair and possibly reduced body hair. This syndrome has been described in only a very small number of families in the medical literature. The skeletal dysplasia can lead to progressive joint problems and disproportionate short stature. Additional features may include dental anomalies and mild facial dysmorphism in some reported cases. The condition is classified under ICD-10 code Q77.7, which encompasses spondyloepiphyseal dysplasia. There is currently no specific cure or targeted therapy for this condition. Management is supportive and multidisciplinary, involving orthopedic monitoring for skeletal complications, physical therapy to maintain mobility, and dermatologic assessment for hair and skin concerns. Growth monitoring and management of any associated complications are important components of ongoing care.

Common questions about Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome